Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Public Health|November 1, 2021
Quantifying the Effects of Climate Factors on Carbon Monoxide Poisoning: A Retrospective Study in TaiwanChien-Ho Wang, Shih-Chieh Shao, Kai-Cheng Chang, et al.
Nature Communications|January 28, 2021
APE1 distinguishes DNA substrates in exonucleolytic cleavage by induced space-fillingTung-Chang Liu, Chun-Ting Lin, Kai-Cheng Chang, et al.
Cardiovascular Diabetology|October 10, 2020
Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysisKai-Cheng Chang, Shih-Chieh Shao, Shihchen Kuo, et al.
International Journal of General Medicine|September 11, 2023
Risk of Thrombosis Following the First Dose of ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Maintenance Hemodialysis: A Self-Controlled Case Series StudyShih-Chieh Shao, Tzu-Chi Liao, Kai-Cheng Chang, et al.
Cardiovascular Diabetology|October 24, 2021
Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular diseaseShih-Chieh Shao, Kai-Cheng Chang, Swu-Jane Lin, et al.
BMJ Open Diabetes Research & Care|February 12, 2020
Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients?Shih-Chieh Shao, Yi-Han Lin, Kai-Cheng Chang, et al.
Cancer Medicine|June 6, 2023
Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real-world experiencePo-Ting Lin, Min-Hua Hung, Shih-Chieh Shao, et al.
Cardiovascular Diabetology|February 14, 2020
Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patientsShih-Chieh Shao, Kai-Cheng Chang, Swu-Jane Lin, et al.
Cardiovascular Diabetology|September 26, 2019
Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort studyShih-Chieh Shao, Kai-Cheng Chang, Ming-Jui Hung, et al.
Diabetes, Obesity & Metabolism|September 6, 2019
Effects of sodium-glucose co-transporter-2 inhibitors on serum alanine aminotransferase levels in people with type 2 diabetes: A multi-institutional cohort studyShih-Chieh Shao, Kai-Cheng Chang, Rong-Nan Chien, et al.
Pageof 3